KCTD16 Antikörper (N-Term)
-
- Target Alle KCTD16 Antikörper anzeigen
- KCTD16 (Potassium Channel Tetramerisation Domain Containing 16 (KCTD16))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser KCTD16 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- KCTD16 antibody was raised against the N terminal of KCTD16
- Aufreinigung
- Affinity purified
- Immunogen
- KCTD16 antibody was raised using the N terminal of KCTD16 corresponding to a region with amino acids KREAEYFQLPDLVKLLTPDEIKQSPDEFCHSDFEDASQGSDTRICPPSSL
- Top Product
- Discover our top product KCTD16 Primärantikörper
-
-
- Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
KCTD16 Blocking Peptide, catalog no. 33R-4621, is also available for use as a blocking control in assays to test for specificity of this KCTD16 antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of KCTD16 antibody in PBS
- Konzentration
- Lot specific
- Buffer
- PBS
- Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Target
- KCTD16 (Potassium Channel Tetramerisation Domain Containing 16 (KCTD16))
- Andere Bezeichnung
- KCTD16 (KCTD16 Produkte)
- Hintergrund
- KCTD16 is an auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. It increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization.
- Molekulargewicht
- 49 kDa (MW of target protein)
- Pathways
- Synaptic Membrane, Regulation of G-Protein Coupled Receptor Protein Signaling
-